Showing 551-560 of 2425 results for "".
Cannabinoids and the Endocannabinoid System: Emerging Trends
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-the-endocannabinoid-system-emerging-trends/30406/Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.Pharmaceutical Treatment of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pharmaceutical-treatment-of-parkinsons-disease/30242/The best outcomes rely on a handful of medicines and partnership among clinicians, patients, and caregivers.- Letters to the Editor: The tPA Debate Continues: “Dr. Anonymous” Respondshttps://practicalneurology.com/columns/practice-management/letters-to-the-editor-the-tpa-debate-continues-dr-anonymous-responds/31488/Ongoing Debate on tPA Use in Acute Stroke ManagementAn anonymous physician from Oklahoma responds to prior discussions on the use of tissue plasminogen activator (tPA) in acute stroke treatment, emphasizing a cautious approach grounded in ethical and practical considerations. The physician clarifies
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0708Epilepsy-pdf/31003/Complementary and Alternative Medical Therapies (CAMs) are increasingly utilized by patients with epilepsy, highlighting the necessity for healthcare professionals to be vigilant about their potential impacts. CAMs encompass a variety of treatments, including herbal medicines, dietary supplements, a
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31058/The January 2008 issue of *Practical Neurology* features a distinguished editorial board and contributor lineup, underscoring the journal’s commitment to advancing neurological medicine. Led by Dr. Stephen Gollomp, Chief of Neurology at Lankenau Hospital and Clinical Professor at Thomas Jefferson Un
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1206Epilepsy-pdf/31237/The Role of Generic Antiepileptic Drugs in Epilepsy ManagementEffective epilepsy treatment aims to achieve seizure freedom without adverse side effects. According to Kwan and Brodie, approximately 64% of patients reach this goal using either monotherapy or a combination of two antiseizure medication
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0905-epilepsyessentials-pdf/31399/Allergic Reactions to Antiepileptic Drugs: Clinical Insights and ManagementAllergic reactions to antiepileptic drugs (AEDs) are a significant concern for healthcare professionals, presenting primarily as cutaneous manifestations. These reactions range from mild rashes to severe, life-threatening con
Stroke Snapshot: Carotid Artery Webs—Epidemiology and Pathophysiology
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-carotid-artery-webs-epidemiology-and-pathophysiology/32158/Carotid artery webs—nonatheromatous, shelf-like projections arising from the tunica intima of the posterior carotid wall—are suspected to be a cause of otherwise cryptogenic strokes.Lewy Body Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/lewy-body-dementia-1/31536/The second highest cause of dementia is highly variable.